Vanguard Group’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $183M | Buy |
|
|||||
2025
Q1 | $157M | Buy |
|
|||||
2024
Q4 | $168M | Buy |
|
|||||
2024
Q3 | $160M | Buy |
|
|||||
2024
Q2 | $168M | Sell |
|
|||||
2024
Q1 | $262M | Sell |
|
|||||
2023
Q4 | $377M | Buy |
|
|||||
2023
Q3 | $291M | Sell |
|
|||||
2023
Q2 | $438M | Buy |
|
|||||
2023
Q1 | $416M | Buy |
|
|||||
2022
Q4 | $342M | Buy |
|
|||||
2022
Q3 | $346M | Buy |
|
|||||
2022
Q2 | $450M | Buy |
|
|||||
2022
Q1 | $955M | Buy |
|
|||||
2021
Q4 | $1.21B | Buy |
|
|||||
2021
Q3 | $1.65B | Buy |
|
|||||
2021
Q2 | $2.05B | Buy |
|
|||||
2021
Q1 | $2.17B | Buy |
|
|||||
2020
Q4 | $2.29B | Buy |
|
|||||
2020
Q3 | $1.58B | Buy |
|
|||||
2020
Q2 | $1.32B | Buy |
|
|||||
2020
Q1 | $1.06B | Buy |
|
|||||
2019
Q4 | $558M | Buy |
|
|||||
2019
Q3 | $447M | Buy |
|
|||||
2019
Q2 | $417M | Buy |
|
|||||
2019
Q1 | $342M | Buy |
|
|||||
2018
Q4 | $301M | Buy |
|
|||||
2018
Q3 | $507M | Buy |
|
|||||
2018
Q2 | $269M | Buy |
|
|||||
2018
Q1 | $176M | Buy |
|
|||||
2017
Q4 | $136M | Buy |
|
|||||
2017
Q3 | $116M | Buy |
|
|||||
2017
Q2 | $106M | Buy |
|
|||||
2017
Q1 | $68.2M | Buy |
|
|||||
2016
Q4 | $30M | Buy |
|
|||||
2016
Q3 | $32.2M | Buy |
|
|||||
2016
Q2 | $21.7M | Buy |
|
|||||
2016
Q1 | $10.2M | Buy |
|
|||||
2015
Q4 | $11.1M | Buy |
|
|||||
2015
Q3 | $12.2M | Buy |
|